LMAT · NASDAQ · STOCK
LeMaitre Vascular (LMAT) Stock Analysis
$80.67
52W $78.22 – $118.01
58/100
$1.84B
27.8
0.47
Is LMAT Bullish or Bearish?
Bullish.
Innellis AI committee rates LeMaitre Vascular, Inc. (LMAT) Buy with a composite score of 58/100
, based on 5 analysts with 60% agreement.
Last updated October 10, 2026.
What Would Change This View
- Upgrade to Strong Buy
- Requires a committee score of 75.0 — +17.00 from today. Applies on the first day at or above the line; upgrades are never dampened.
- Downgrade to Watch
- Requires the score to fall below 55.0 — -3.00 from today. The band boundary is 60.0, but a one-step downgrade must clear a further margin first. A score oscillating around the line should not change the rating every night.
Executive Summary
The committee is genuinely divided. Growth Analyst sees a compelling case — eps growing 34.4% yoy. Portfolio Manager remains cautious — sector concentration is already high (hhi 2796.97). This disagreement is itself the signal — the setup is not clean in either direction.
Bull & Bear Case
Bull Case
- ROE of 16.4% shows genuine earnings power backing the valuation — Value
- EPS growing 34.4% YoY — Growth
- Quarter-over-quarter growth rate is ACCELERATING, not just positive — Growth
- MACD histogram positive -- bullish momentum — Technical
Bear Case
- P/E of 27.7 is moderate-to-rich — Value
- Price-to-book of 4.7x prices in significant intangible value — Value
- Price structure making lower highs and lower lows — Technical
- Daily trend (downtrend) conflicts with the weekly trend (uptrend) -- fighting the larger trend — Technical
- News sentiment is negative (-0.33 across 3 articles, 14d) — News
Both cases are generated from quantitative data signals, not qualitative or
forward-looking judgement. They summarise what the numbers say today.
Price History (6M)
AI Investment Committee
Committee Consensus
As of October 10, 2026
Overall Committee Score
58/100
Agreement
60%
Analysts
5
Conviction
Moderate
Sector Rank
Top 45%
of 192 Healthcare peers
Value Analyst
neutral
54
/ 100 · High confidence
Fair value -- neither a bargain nor obviously overpriced
+ ROE of 16.4% shows genuine earnings power backing the valuation
− P/E of 27.7 is moderate-to-rich
Growth Analyst
bullish
78
/ 100 · High confidence
Strong, accelerating growth with consistent execution
+ EPS growing 34.4% YoY
Technical Analyst
neutral
46
/ 100 · High confidence
Mixed or range-bound price action
+ MACD histogram positive -- bullish momentum
− Price structure making lower highs and lower lows
Macro Analyst
bullish
65
/ 100 · Low confidence
Macro backdrop is supportive of risk assets generally, and this name's beta works in its favor
News Analyst
neutral
47
/ 100 · Low confidence
News flow is mixed or quiet -- no strong signal either way right now
− News sentiment is negative (-0.33 across 3 articles, 14d)
Portfolio Manager
bearish
30
/ 100 · Moderate confidence
The existing book itself argues for caution here, independent of how good this specific stock looks
− Sector concentration is already high (HHI 2796.97)
Investment Thesis Evolution
Committee score moved marginally from 58.0 to 58.0.
- New bearish signals: 1 appeared.
- Bearish pressure eased: 1 signal(s) disappeared.
Analyst-level changes:
- Value Analyst: +1 bearish signal(s).
Comparing 2026-10-09 to 2026-10-10 (1 day apart).
Technical Analysis
RSI (14)
52.5
Neutral
MACD Histogram
0.135
Bullish Momentum
Trend Direction
Downtrend
Weekly: Uptrend
Market Structure
Mixed
Support
$79.75
Resistance
$91.56
Bollinger %B
0.54
Inside Bands
Price vs Moving Averages
EMA 9
$80.23
Above
EMA 21
$80.65
Above
EMA 50
$83.52
Below
EMA 200
$91.10
Below
Fundamental Analysis
Valuation
68
Growth
59
Profitability
92
Financial Health
100
Cash Flow
70
Valuation
P/E Ratio
27.8×
P/B Ratio
4.39×
PEG Ratio
0.73
Dividend Yield
1.18%
52W High
$118.01
52W Low
$78.22
Quality & Growth
ROE
1467.1%
ROA
937.7%
Gross Margin
7289.7%
Operating Margin
2946.2%
Revenue Growth YoY
—
Debt / Equity
0.45
AI Fundamental Assessment
P/E ratio of 27.8 (moderate relative to a 15-40x range); Price-to-book of 4.4x; PEG ratio of 0.7 (under 1.0 suggests growth is undervalued relative to price); Return on equity of 14.7%; Return on assets of 9.4%; Net margin of 25.0%; Gross margin of 72.9%; Current ratio of 16.31 (healthy short-term liquidity); Debt-to-equity of 0.45; Free cash flow per share is positive (3.23); Most recent quarter missed estimates by 10.1%; EPS growth accelerating (+0.0% -> +8.8% QoQ); Analyst estimates rising over recent quarters
Get the Full LMAT Analysis
Interactive charts · Live committee votes · Trade plan · Paper trading · AI Q&A
Open in Terminal →